Amicus Therapeutics is Changing The Globe for The Better

Amicus Therapeutics is a global Biotechnology company. It concentrates its efforts on curing or managing over 7,000 rare diseases with technology and medicine. It was found in 2002 with its headquarters still in Cranbury, NJ. The remarkable work that Amicus Therapeutics has done and will continue to do has benefited people globally.

How has Amicus Therapeutics helped people?


Amicus Therapeutics continues to develop technologies and medicines that will help the small percentage of the population that is affected by these devastating genetic diseases. For example, The Global Wire News put out a press release earlier this year for Amicus Therapeutics (Crunchbase). It states that the biotech company has “plans to submit a new drug application (NDA) to the U.S. FDA for the oral precision medicine migalastat for Fabry disease in the fourth quarter of 2017”. Amicus Therapeutics is recognized as a global biotechnology company, therefore, it is no surprise that a press release was posted on their official website stating that “they put in an application to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan for the same drug to be released there.” To check for more update on new tech and medicine visit


Success stories


Amicus Therapeutics have many success stories of people who have used a technology or medicine that has assisted them with their rare devastating diseases.


For example, Mike, who had been misdiagnosed for nine years with Polymyositis. He was sent to the hospital one day thinking that he would never leave there, had to take a muscle biopsy three times before the doctors accurately diagnosed with Pompe disease. Because Mike was misdiagnosed, Pompe had weakened the skeletal muscles of Mike’s diaphragm that allowed him to breathe. Therefore, he had to stay in the hospital for years. Until one day he heard from a friend about a device that helps spinal-cord injury patients breathe on their own.


Mike was the first person to try out this new technology and it proved to be successful. Finally, on October 18, 2012, Mike could go home and be with his family.


Where to find more information about Amicus Therapeutics?


You can find more information about Amicus Therapeutics by visit